| Retinoic acid and arsenic trioxide for acute promyelocytic leukemia F Lo-Coco, G Avvisati, M Vignetti, C Thiede, SM Orlando, S Iacobelli, ... New England Journal of Medicine 369 (2), 111-121, 2013 | 1793* | 2013 |
| Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA … MA Sanz, FL Coco, G Martın, G Avvisati, C Rayón, T Barbui, ... Blood, The Journal of the American Society of Hematology 96 (4), 1247-1253, 2000 | 838 | 2000 |
| High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial AJM Ferreri, M Reni, M Foppoli, M Martelli, GA Pangalis, M Frezzato, ... The Lancet 374 (9700), 1512-1520, 2009 | 741 | 2009 |
| The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia P Rebulla, G Finazzi, F Marangoni, G Avvisati, L Gugliotta, G Tognoni, ... New England Journal of Medicine 337 (26), 1870-1875, 1997 | 694 | 1997 |
| Molecular Remission in PML/RARα-Positive Acute Promyelocytic Leukemia by Combined All-trans Retinoic Acid and Idarubicin (AIDA) Therapy F Mandelli, D Diverio, G Avvisati, A Luciano, T Barbui, C Bernasconi, ... Blood, The Journal of the American Society of Hematology 90 (3), 1014-1021, 1997 | 653 | 1997 |
| Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet MA Sanz, P Fenaux, MS Tallman, EH Estey, B Löwenberg, T Naoe, ... Blood, The Journal of the American Society of Hematology 133 (15), 1630-1643, 2019 | 611 | 2019 |
| Mucormycosis in hematologic patients L Pagano, M Offidani, L Fianchi, A Nosari, A Candoni, M Picardi, ... haematologica 89 (2), 207-214, 2004 | 496* | 2004 |
| Zoledronic acid induces significant and long-lasting modifications of circulating angiogenic factors in cancer patients D Santini, B Vincenzi, G Dicuonzo, G Avvisati, C Massacesi, F Battistoni, ... Clinical Cancer Research 9 (8), 2893-2897, 2003 | 477 | 2003 |
| Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: an overview of 6,633 patients from 27 randomized trials. M Pasquali, J Vela, R Kyle, T Leong, E Fritz, S Suciu, IP Palva, T Oivanen, ... Journal of Clinical Oncology 16 (12), 3832-3842, 1998 | 443 | 1998 |
| Maintenance treatment with recombinant interferon alfa-2b in patients with multiple myeloma responding to conventional induction chemotherapy F Mandelli, G Avvisati, S Amadori, M Boccadoro, A Gernone, VM Lauta, ... New England Journal of Medicine 322 (20), 1430-1434, 1990 | 442 | 1990 |
| Arsenic trioxide as an inducer of apoptosis and loss of PML/RARα protein in acute promyelocytic leukemia cells W Shao, M Fanelli, FF Ferrara, R Riccioni, A Rosenauer, K Davison, ... JNCI: Journal of the National Cancer Institute 90 (2), 124-133, 1998 | 439 | 1998 |
| Improved outcomes with retinoic acid and arsenic trioxide compared with retinoic acid and chemotherapy in non–high-risk acute promyelocytic leukemia: final results of the … U Platzbecker, G Avvisati, L Cicconi, C Thiede, F Paoloni, M Vignetti, ... Journal of Clinical Oncology 35 (6), 605-612, 2017 | 433 | 2017 |
| Therapy with high-dose dexamethasone (HD-DXM) in previously untreated patients affected by idiopathic thrombocytopenic purpura: a GIMEMA experience MG Mazzucconi, P Fazi, S Bernasconi, G De Rossi, G Leone, L Gugliotta, ... Blood 109 (4), 1401-1407, 2007 | 410 | 2007 |
| Triazene compounds: mechanism of action and related DNA repair systems F Marchesi, M Turriziani, G Tortorelli, G Avvisati, F Torino, L De Vecchis Pharmacological research 56 (4), 275-287, 2007 | 402 | 2007 |
| Front-line treatment of acute promyelocytic leukemia with AIDA induction followed by risk-adapted consolidation for adults younger than 61 years: results of the AIDA-2000 trial … F Lo-Coco, G Avvisati, M Vignetti, M Breccia, E Gallo, A Rambaldi, ... Blood, The Journal of the American Society of Hematology 116 (17), 3171-3179, 2010 | 387 | 2010 |
| Early detection of relapse by prospective reverse transcriptase-polymerase chain reaction analysis of the PML/RARα fusion gene in patients with acute promyelocytic leukemia … D Diverio, V Rossi, G Avvisati, S DeSantis, A Pistilli, F Pane, G Saglio, ... Blood, The Journal of the American Society of Hematology 92 (3), 784-789, 1998 | 369 | 1998 |
| Pamidronate induces modifications of circulating angiogenetic factors in cancer patients D Santini, B Vincenzi, G Avvisati, G Dicuonzo, F Battistoni, M Gavasci, ... Clinical Cancer Research 8 (5), 1080-1084, 2002 | 365 | 2002 |
| Clinical outcome of extramedullary plasmacytoma P Galieni, M Cavo, A Pulsoni, G Avvisati, C Bigazzi, S Neri, U Caliceti, ... Haematologica 85 (1), 47-51, 2000 | 362 | 2000 |
| Early deaths and anti-hemorrhagic treatments in acute promyelocytic leukemia. A GIMEMA retrospective study in 268 consecutive patients [see comments] F Rodeghiero, G Avvisati, G Castaman, T Barbui, F Mandelli | 326 | 1990 |
| AIDA (all-trans retinoic acid+ idarubicin) in newly diagnosed acute promyelocytic leukemia: a Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) pilot study G Avvisati, F Lo Coco, D Diverio, M Falda, F Ferrara, M Lazzarino, ... | 305 | 1996 |
